Juan Nogues - Pharma Mar Director Sales

All Insiders . Spain . 
Stock . Pharma Mar SA . Stakeholders . Insider . Juan Nogues
PHM Stock  EUR 75.60  2.10  2.86%   

Insider

Juan Nogues is Director Sales of Pharma Mar SA
Phone34 91 846 60 00
Webhttps://www.pharmamar.com

Pharma Mar Management Efficiency

The company has return on total asset (ROA) of 0.1326 % which means that it generated a profit of $0.1326 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4705 %, meaning that it generated $0.4705 on every $100 dollars invested by stockholders. Pharma Mar's management efficiency ratios could be used to measure how well Pharma Mar manages its routine affairs as well as how well it operates its assets and liabilities.
Pharma Mar SA has accumulated 33.39 M in total debt. Pharma Mar SA has a current ratio of 0.92, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Pharma Mar until it has trouble settling it off, either with new capital or with free cash flow. So, Pharma Mar's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pharma Mar SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pharma to invest in growth at high rates of return. When we think about Pharma Mar's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Nuria LapeaGrifols SA
59
Luis MartinInternational Consolidated Airl
N/A
Nicholas FCAInternational Consolidated Airl
57
Angel NaveirasMelia Hotels
Andrew LightInternational Consolidated Airl
N/A
Steven JDGrifols SA
63
Vincent HodderInternational Consolidated Airl
51
Alvaro HernandezInternational Consolidated Airl
N/A
Juan MaosoCellnex Telecom SA
N/A
Dario ClementeSolaria Energa y
N/A
Carolina MartinoliInternational Consolidated Airl
53
Jose LarranagaSolaria Energa y
N/A
Alfredo GuerraGrifols SA
65
Fernando CandelaInternational Consolidated Airl
N/A
David BellGrifols SA
69
Andr GerondeauMelia Hotels
N/A
Raimon RouraGrifols SA
59
Yolanda MartinezCellnex Telecom SA
N/A
M TubauGrifols SA
N/A
Alfonso IglesiasSolaria Energa y
N/A
John GibbsInternational Consolidated Airl
N/A
Pharma Mar, S.A., a biopharmaceutical company, engages in the discovery and development of marine-derived anticancer drugs in Spain and internationally. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain. PHARMA MAR operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 599 people. Pharma Mar SA (PHM) is traded on Madrid Exchange in Spain and employs 477 people.

Management Performance

Return On Equity0.47
Return On Asset0.13

Pharma Mar SA Leadership Team

Elected by the shareholders, the Pharma Mar's board of directors comprises two types of representatives: Pharma Mar inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharma. The board's role is to monitor Pharma Mar's management team and ensure that shareholders' interests are well served. Pharma Mar's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharma Mar's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pedro Puentes, Ex ViceChairman
Jose SousaFaro, Ex Founder
Sandra Sanchez, Global Head
Elena Crespo, Director Admin
Jos MartinezLosa, Director Relations
Mara Caballero, Chief Officer
Juan Nogues, Director Sales
Juan Carretero, Founder
Lara Vadillo, Communication Director
Juan Pulido, Gen Directors

Pharma Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pharma Mar a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.47
Return On Asset0.13
Profit Margin0.35 %
Operating Margin0.33 %
Current Valuation1.07 B
Shares Outstanding18.09 M
Shares Owned By Insiders26.95 %
Shares Owned By Institutions10.48 %
Price To Earning(38.29) X
Price To Book5.69 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Other Information on Investing in Pharma Stock

Pharma Mar financial ratios help investors to determine whether Pharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharma with respect to the benefits of owning Pharma Mar security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY